Toxic shock syndrome primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:


== Primary Prevention ==
== Primary Prevention ==
* The spread of all types of group A streptococcal infections can be reduced by good hand washing, especially after coughing and sneezing and before preparing foods or eating.
* The spread of all types of group A streptococcal infections can be reduced by good hand washing, especially after coughing and sneezing and before preparing foods or eating.<ref name="urlGroup A Strep | Group A Streptococcus Diseases | GAS | CDC">{{cite web |url=https://www.cdc.gov/groupastrep/diseases-public/index.html |title=Group A Strep &#124; Group A Streptococcus Diseases &#124; GAS &#124; CDC |format= |work= |accessdate=}}</ref>
* Menstrual toxic shock syndrome can be prevented by avoiding the use of tampons, especially the super absorbent variety. Risk can be reduced by changing tampons more frequently.
* Menstrual toxic shock syndrome can be prevented by avoiding the use of tampons, especially the super absorbent variety. Risk can be reduced by changing tampons more frequently.


Line 15: Line 15:
* It is not necessary for all people exposed to someone with an invasive group A streptococcal TSS to receive antibiotic therapy to prevent infection. However, in certain circumstances, antibiotic therapy may be appropriate.
* It is not necessary for all people exposed to someone with an invasive group A streptococcal TSS to receive antibiotic therapy to prevent infection. However, in certain circumstances, antibiotic therapy may be appropriate.


Centers for Disease Control and Prevention. GAS frequently asked questions. May 2014. <nowiki>http://www.cdc.gov</nowiki> (last accessed 9 January 2017)


Avoiding extended tampon use has decreased the incidence of staphylococcal TSS. Lack of seroconversion after an acute staphylococcal illness may be used as a marker for patients at risk for recurrent disease. These patients should be treated for a protracted course with antistaphylococcal antibodies for at least 2 weeks
Avoiding extended tampon use has decreased the incidence of staphylococcal TSS. Lack of seroconversion after an acute staphylococcal illness may be used as a marker for patients at risk for recurrent disease. These patients should be treated for a protracted course with antistaphylococcal antibodies for at least 2 weeks
* Experimental staphylococcal vaccines and immunotherapies in clinical trials.
* Experimental staphylococcal vaccines and immunotherapies in clinical trials.


PMCID: PMC3102526
PMCID: <ref name="pmid21625323">{{cite journal |vauthors=Lin YC, Peterson ML |title=New insights into the prevention of staphylococcal infections and toxic shock syndrome |journal=Expert Rev Clin Pharmacol |volume=3 |issue=6 |pages=753–767 |year=2010 |pmid=21625323 |pmc=3102526 |doi=10.1586/ecp.10.121 |url=}}</ref>
===Template===
===Template===
====Primary Prevention====
====Primary Prevention====

Revision as of 15:30, 15 May 2017

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome primary prevention

CDC on Toxic shock syndrome primary prevention

Toxic shock syndrome primary prevention in the news

Blogs on Toxic shock syndrome primary prevention

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Toxic shock syndrome (TSS) can be prevented by hygiene increase.

Primary Prevention

  • The spread of all types of group A streptococcal infections can be reduced by good hand washing, especially after coughing and sneezing and before preparing foods or eating.[1]
  • Menstrual toxic shock syndrome can be prevented by avoiding the use of tampons, especially the super absorbent variety. Risk can be reduced by changing tampons more frequently.
  • Patients with confirmed strep throat should stay at home until 24 hours after commencing antibiotic treatment.
  • All wounds should be kept clean and watched for possible signs of infection such as redness, swelling, drainage, and pain at the wound site.
  • It is not necessary for all people exposed to someone with an invasive group A streptococcal TSS to receive antibiotic therapy to prevent infection. However, in certain circumstances, antibiotic therapy may be appropriate.


Avoiding extended tampon use has decreased the incidence of staphylococcal TSS. Lack of seroconversion after an acute staphylococcal illness may be used as a marker for patients at risk for recurrent disease. These patients should be treated for a protracted course with antistaphylococcal antibodies for at least 2 weeks

  • Experimental staphylococcal vaccines and immunotherapies in clinical trials.

PMCID: [2]

Template

Primary Prevention

  • First Sentences
There are no primary preventive measures available for [disease name].
OR
There is no established method for prevention of [disease name].
OR
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
OR
There are no available vaccines against [disease name]. Primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

  • First Sentences:
Secondary prevention strategies following [disease name] include [strategy 1], [strategy 2], and [strategy 3].

OR

The primary and secondary prevention strategies for [Disease Name] are the same.

Prevention

  • Describe in detail the key methods of preventing the disease you are describing, and preventing conditions that lead up to the disease.
  • A good source to reference is http://www.uspreventiveservicestaskforce.org/index.html.
  • For an example of the prevention segment in the prevention page, click here.
  • Methods of prevention can be divided into primary and secondary prevention measures, as per the microchapter navigation template. To help you determine what type of preventative measures you are describing, refer to the table below.

References

  1. "Group A Strep | Group A Streptococcus Diseases | GAS | CDC".
  2. Lin YC, Peterson ML (2010). "New insights into the prevention of staphylococcal infections and toxic shock syndrome". Expert Rev Clin Pharmacol. 3 (6): 753–767. doi:10.1586/ecp.10.121. PMC 3102526. PMID 21625323.


Template:WikiDoc Sources